This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Aaron Chapman in Allergic Inflammation Detection
Introduction
Aaron Chapman is an innovative inventor based in Los Angeles, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection of allergic inflammation. His work focuses on utilizing blood markers to identify and monitor allergic reactions in individuals.
Latest Patents
Chapman holds a patent for a groundbreaking invention titled "Systemic genotoxicity as blood marker for allergic inflammation." This invention provides a method for detecting allergic inflammation in a subject by assaying a test sample of peripheral blood for markers of DNA damage. An elevated amount of these markers in the test sample, compared to a control sample, indicates inflammation. The method can also be adapted for quantitatively monitoring the efficacy of treatment for allergic inflammation. Markers of DNA damage include single- and/or double-stranded breaks in leukocytes, oxidative DNA damage in leukocytes, or a marker of nitric oxide oxidative activity. This unexpected discovery allows for the detection of allergic inflammation through a relatively simple and minimally invasive assay using peripheral blood.
Career Highlights
Aaron Chapman is affiliated with the University of California, where he continues to advance his research and innovations. His work has the potential to transform how allergic conditions are diagnosed and treated, providing a more efficient and less invasive approach for patients.
Collaborations
Chapman has collaborated with notable colleagues, including Robert H. Schiestl and Daniel Malkin. These partnerships have further enhanced the impact of his research and innovations in the field.
Conclusion
Aaron Chapman's contributions to the detection of allergic inflammation through innovative blood markers represent a significant advancement in medical diagnostics. His work not only improves the understanding of allergic reactions but also paves the way for more effective treatment monitoring.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile